UNION Therapeutics Announces Expansion of Clinical Pipeline: Adds UNI91103 to Prevent COVID-19 and Reduce the Severity of the Diseases Among Those Already Infected
Introduces UNI91103 (intranasal niclosamide) to prevent COVID-19 and reduce the severity of the diseases among those already infected.